Is Stanrose Mafat. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Stanrose Mafat. has moved from risky to very expensive, indicating a significant deterioration in its investment appeal. The company is currently deemed overvalued, supported by a PE ratio of -13.63, an EV to EBITDA of -0.47, and a ROE of -5.31%. These ratios reflect a concerning financial position, particularly the negative earnings metrics which suggest that the company is struggling to generate profits.
In comparison to its peers, Stanrose Mafat. stands out with its negative PE ratio, while Bajaj Finance, for instance, has a PE of 38.21, and Life Insurance boasts a PE of 11.49, both indicating a more favorable valuation. The stark contrast in these ratios reinforces the notion that Stanrose Mafat. is not only overvalued but also underperforming relative to its industry. Additionally, the company's stock has underperformed against the Sensex, with a year-to-date return of -15.50% compared to the Sensex's 7.44%, further highlighting its valuation challenges.